Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Summerton Drug Compounding and Dispensary
483
•Summerton Drug Compounding and Dispensary•October 17, 2014

Summerton Drug Compounding and Dispensary – FDA 483, Oct 17, 2014

Record Details

The FDA Form 483 identifies multiple violations at a drug manufacturing facility. The firm failed to thoroughly investigate potency failures in three lots of CBDC1-A Cream (Lots 1112013(8)1, 01312014(8)4, 04182014(8)4) for Baclofen (84.1%-114.1%), Cyclobenzaprine HCl (88.8%), Diclofenac Sodium (89.0%-98.1%), and Lidocaine (82.8%-99.8%). This violates SOP 9.060 and USP 1201. The firm's procedures (SOP 9.150, SOP 9.060) lack acceptance criteria for finished product testing, contradicting SOP 9.140 which references USP monograph criteria.

The written stability testing program is not followed, as there is no stability data to support the 90-day Beyond Use Dates (BUDs) assigned to products like CBDC1-A Cream, KBCG1-F Cream, DBCG1-Li Cream, and TDCTG Cream, violating SOP 9.050. Batch production records for these products are incomplete, lacking accurate mixing times and specific details. Written production and process control procedures, specifically SOP 9.140,

Company
Summerton Drug Compounding and Dispensary
Inspection date
October 17, 2014
Product type
Drugs
Office
Atlanta District Office
Person
  • Penny MoCarver
View Company Profile

ID · 75639628-ce32-4c92-9be7-931a1f4b7224

Violation Codes3
21 CFR 21021 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Summerton Drug Compounding and Dispensary
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.